MedTrace Logo

Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers

NCT00343629 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2015-04-28

No results posted yet for this study

Summary

RATIONALE: Giving healthy volunteers sulindac capsules or sulindac tablets may help doctors learn which form of the drug may be more effective in preventing cancer.

PURPOSE: This randomized clinical trial is studying sulindac capsules to see how well they work compared with sulindac tablets in healthy volunteers.

Conditions

  • Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

sulindac

OTHER

pharmacological study

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Paul J. Limburg, MD, MPH · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-04-30
Completion
2007-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00343629 on ClinicalTrials.gov